Mobile phase B was composed of 50 vol % acetonitrile (Merck, 100030)/50 vol % MeOH (Sigma, 34860). Figure S1 details the gradient parameters used in the method. Samples from the batch and MCSGP ...

Cheng Xin / Getty Images Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat head and neck cancers. Studies found patients ...

Merck Manuals is launching a new artificial intelligence-powered search tool designed to provide patients with streamlined access to trusted information and resources from its medical manuals.

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat head and neck cancers. Studies found patients taking Keytruda can reduce ...

Merck experienced a 4% price move over the last month, driven by crucial developments in its product offerings. The FDA approval of ENFLONSIA for RSV prevention and the successful clinical trial ...

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Merck’s clesrovimab, which will be marketed under the name Enflonsia, was approved for use in children under the age of 12 months. The wholesale price for Enflonsia has been set at $556 a dose ...

Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed its Neutral rating on Merck & Co., Inc. (NYSE:MRK) with a fixed ...

June 9 (Reuters) - Merck's (MRK.N), opens new tab oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers ...

There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could be a steal of a deal.(Seth Wenig / AP) Shares of pharmaceutical ...

Financial giants have made a conspicuous bullish move on Merck & Co. Our analysis of options history for Merck & Co MRK revealed 30 unusual trades. Delving into the details, we found 60% of ...